National
Frank defends use of ‘Uncle Tom’ remark against Log Cabin
Says gay GOP group’s support for Romney hurts quest for LGBT equality
Rep. Barney Frank (D-Mass.) (Washington Blade photo by Michael Key)
Gay U.S. Rep. Barney Frank (D-Mass.) released a statement on Tuesday seeking to explain why he said during last week’s Democratic National Convention that Log Cabin Republicans use “Uncle Tom” as their “role model.”
R. Clarke Cooper, executive director of Log Cabin, a national gay GOP group, last week blasted Frank for using the Uncle Tom comparison, accusing Frank of “demonizing Republicans and undermining efforts at bipartisanship that would actually improve LGBT Americans’ lives.”
In an interview with the Washington Blade on Tuesday, Frank said that his use of the term, which he admitted was “very harsh,” was aimed at highlighting his belief that Log Cabin leaders were seriously jeopardizing the cause of LGBT equality by campaigning vigorously for a presidential candidate – Mitt Romney — who opposes and would take away policies supporting the rights of LGBT people.
“If you want to say economic issues are more important to me, that the Democrats are environmental extremists – if you want to say that’s why you’re voting for him and say and acknowledge that those issues are more important to them than LGBT issues,” Frank said he understands the logic of that.
“But my problem is when they say it is helpful to LGBT causes to vote for them,” he said.
Frank first invoked the “Uncle Tom” comparison to Log Cabin Republicans during an interview with gay radio host Michelangelo Signorile during the second day of the Democratic convention on Sept. 5. He reiterated the comparison the next day in a speech before the convention’s LGBT Caucus. Frank didn’t use the term during his speech before the full convention on the evening of Sept. 5.
In his own statement released on Sept. 5, Cooper said, “We expect this kind of bile from Barney, especially when it plays into the Obama campaign’s efforts to divide, distract and deceive the American people.”
Added Cooper, “Frank calls us ‘Uncle Toms’ and pretends that Log Cabin hasn’t been on the front lines of the fight for equality. The truth is, by speaking conservative to conservatives about gay rights, Log Cabin republicans are doing some of the hardest work in the movement, work that liberals like Barney are unwilling to do and couldn’t do if they tried.”
In his statement this week, Frank said, “I am not surprised that members of Log Cabin Republicans are offended by my comparing them to Uncle Tom. They are no more offended than I am by their campaigning in the name of LGBT rights to elect the candidate and party who diametrically oppose our rights against a president who has forcefully and effectively supported our rights.”
Frank says in his statement that Cooper and other Log Cabin officials have defended their support for Romney and other GOP candidates who don’t support LGBT rights by saying “they have succeeded in getting the Republicans to reduce the extent to which they denounce us.” He notes that Cooper says Rep. Paul Ryan (R-Wisc.), Romney’s vice presidential candidate, is willing to “engage” with gay Republicans.
“That is where Uncle Tom comes to mind,” Frank says in his statement. “They are urging people to vote for the anti-LGBT candidate over the most supportive LGBT candidate and platform imaginable because the ‘antis’ are calling us fewer names and are willing to talk to some of us,” Frank said.
“It is this willingness to acquiesce in a subordinate status as long as the masters are kinder in tone, although [not] in substance, that emulates Uncle Tom,” he said.
The full text of Frank’s statement of Sept. 11 follows.
WASHINGTON – Congressman Barney Frank today released the following statement as a follow-up to his recent comments during the Democratic National Convention about the Log Cabin Republicans.
I am not surprised that members of the Log Cabin Republicans are offended by my comparing them to Uncle Tom. They are no more offended than I am by their campaigning in the name of LGBT rights to elect the candidate and party who diametrically oppose our rights against a President who has forcefully and effectively supported our rights.
That is the first reason for my admittedly very harsh criticism. This election is clearly one in which there is an extremely stark contrast between the two parties on LGBT rights. The Democratic President and platform fully embrace all of the legal issues we are seeking to resolve in favor of equality. The Republican candidate for President and the platform on which he runs vehemently oppose us in all cases. On the face of this, for a group of largely LGBT people to work for our strong opponent against our greatest ally is a betrayal of any supposed commitment to our legal equality.
But my use of “Uncle Tom” was based not simply on this awful fact that they have chosen to be actively on the wrong side of an election that will have an enormous impact on our right to equality, both in fact and in the public perception of the popularity of that cause. If the Log Cabin Republicans – or their even more outlandish cousins, the oddly-named GOProud –were honestly to acknowledge that they let their own economic interests, or their opposition to strong environmental policies, or their belief that we need to be spending far more on the military or some other reason ahead of any commitment to LGBT equality, and on that ground have decided to prefer the anti-LGBT candidate to the supportive one, I would disagree with the values expressed, but would have no complaint about their logic.
The damaging aspect of the Log Cabin argument, to repeat the most important point, is that they may mislead people who do not share their view that tax cuts for the wealthy are more important than LGBT rights into thinking that they are somehow helping the latter by supporting Mitt Romney and his Rick Santorum platform.
It is a good thing for Republicans to try to influence other Republicans to be supportive of LGBT rights. The problem is when they pretend to be successful when they haven’t been, and urge people to join them in rewarding the Republicans when they have in fact continued their anti-LGBT stance. I have been hearing the Log Cabin Republicans proclaim for years that they were improving the view of that party towards our legal equality. In fact, over the past 20 years, things have gotten worse, not better. Most recently, on DOMA, when the House Republicans offered an amendment to reaffirm it, they voted 98% in favor of it, while Democrats voted more than 90% against the amendment. And it is not surprising that they have not been successful. Giving strong political support to people who are maintaining their anti-LGBT stance is hardly an effective strategy for getting them to change it.
The argument Mr. Cooper and the others in the Log Cabin Republicans have put forward in their defense is that they have succeeded in getting the Republicans to reduce the extent to which they denounce us, and, in Mr. Cooper’s phrase, the fact that Paul Ryan is “willing to engage” with gay Republicans. That is where Uncle Tom comes to mind. They are urging people to vote for the anti-LGBT candidate over the most supportive LGBT candidate and platform imaginable because the “antis” are calling us fewer names and are willing to talk to some of us. It is this willingness to acquiesce in a subordinate status as long as the masters are kinder in tone, although in substance, that emulates Uncle Tom.
I note Mr. Cooper points to a couple of Republicans as reasons for supporting that party and helping advance its anti-LGBT crusade. As to Representative Ryan, in addition to his “willingness to engage with them,” Mr. Cooper cites his vote for the Employment Nondiscrimination Act. In fact, Paul Ryan has an overwhelmingly anti-LGBT voting record, including opposition to the repeal of “Don’t Ask, Don’t Tell,” and a transgender-inclusive hate crimes bill, and support for a constitutional amendment not just to ban future same-sex marriages but to dissolve existing ones. It is true that on one occasion he voted for ENDA, but he did so only after voting minutes before for a Republican procedural maneuver – a motion to recommit the bill – which falsely invoked the specter that passage of ENDA would compel same-sex marriage and which, if it had passed, would have killed the bill. In other words, Paul Ryan has always voted against us, except for one occasion when he voted for us only after first trying to make the bill he theoretically supported inoperative.
Mr. Cooper also cites Susan Collins. She was very good on the question of “Don’t Ask, Don’t Tell.” But the argument that supporting Susan Collins advances LGBT rights ignores the fact that Senator Collins has twice defeated Democrats who were far more supportive of our issues than she was. And an example of that is the current referendum in the state of Maine on marriage. We have a very good chance of winning in Maine, and winning a referendum is important both for the substantive rights of the people in Maine and for the political point that it demonstrates. Unlike the two Democratic Representatives from Maine, Chellie Pingree and Mike Michaud, Susan Collins has been stubbornly silent. That is, in a state where marriage is on the ballot, and in a year in which she is not up for reelection, Senator Collins is withholding her support from us, unlike any Democrat who would have run against her. And remember, these are the best that the Log Cabin Republicans can cite.
Some have complained that in comparing the Log Cabin Republicans to Uncle Tom, I was ignoring the fact that they are nice. I accept the fact that many of them are nice – so was Uncle Tom – but in both cases, they’ve been nice to the wrong people.
ADDENDUM
Recent headlines in the Washington Blade make the point as clearly as I did. In the August 10th issue, a headline proclaims that the “Log Cabin seeks to purge anti-gay language from Republican [platform] document.” In the August 31st issue, another headline states that “Republicans affirm anti-gay views in platform, speeches.” In the September 7th issue, a third headline reports that “Democrats embrace marriage; hundreds of LGBT delegates take part.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Looking back at the 10 biggest A&E stories of 2025
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
